Forensic Analysis · Technology / Software · as of Aug 11, 2026
Tempus Ai, Inc. (TEM)
A forensic read on Tempus Ai, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Safe
Financial health
4.0
Distress distance
Watch
Earnings quality
5
Forensic signals
-35.9
P / E (ttm)
-49.9%
ROE
$10.0B
Market cap
0.00%
Dividend yield
83.4%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Tempus Ai, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 4.0, placing it in the Safe zone. 5 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-15.4%
FY2025
Return on invested capital.Return on invested capital is -15.4% in the latest fiscal year and rising from -186% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
+45.4%/yr
FY2024–FY2025
Share-count dilution.Diluted share count changed +45% over the last 1 year to FY2025 (+45.4%/yr). The count is growing: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~45.4% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2024 has been diluted ~31%.
FCF ($239M)
FY2025
Shareholder returns.Returned $3M to shareholders (buybacks + dividends) in FY2025, but free cash flow was ($239M) after capex — there was no free cash flow to fund the payout from at all, and operating cash flow itself was negative or zero that year too. The entire return is coming from debt or cash reserves, not cash the business itself generated — a harder case than returns merely running ahead of free cash flow, since here there was none to run ahead of.
89d DSO
FY2024→FY2025
Receivables vs revenue.Days sales outstanding moved from 81 to 89 days FY2024→FY2025 (receivables +101% vs revenue +83%). Receivables grew, but deferred revenue grew +22% over the same period too — rising alongside rising unearned revenue reads as upfront billing on multi-period contracts, not slipping collections. There's no FY2023 figure on file for receivables, so FY2024 has no opening balance to average against — both figures are measured on period-end balances rather than the beginning-plus-ending average, since averaging only the current year would make the move track balance-sheet growth rather than the business.
Key fundamentals
Latest Revenue$1.27B
Revenue Growth YoY+83.4%
Net Margin-19.3%
Free Cash Flow-$239.1M
Return on Equity-49.9%
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Tempus Ai, Inc.'s actual 10-K/10-Q/8-K filings?
Data from SEC EDGAR public filings · metrics as of Aug 11, 2026. Forensic signals flag probability, not certainty.
10% of rev
FY2025
Stock-based comp load.Stock-based compensation ran 10% of revenue in FY2025. The cost of it is not in the cash flow — no cash left the business — it is in the count, and there it has run at about 45.4% a year, small enough that totals and per-share results tell the same story.
Tempus Ai, Inc. (TEM) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy